Growth Metrics

AC Immune (ACIU) Debt to Equity (2017 - 2020)

AC Immune (ACIU) reported Debt to Equity of $0.0 for Q3 2020, down 38.41% year-over-year from $0.0 in Q4 2019, and up 3.87% on a QoQ basis from $0.0 in Q2 2020.

AC Immune (ACIU) has 4 years of Debt to Equity data on file, last reported at $0.0 in Q3 2020.

  • Quarterly Debt to Equity fell 38.41% year-over-year to $0.0 in Q3 2020, while the trailing twelve-month figure through Sep 2020 was $0.0 (down 38.41% YoY) and the FY2019 annual result came in at $0.0, down 17.94% from the prior year.
  • Debt to Equity improved to $0.0 in Q3 2020 per ACIU's latest filing, from $0.0 in the prior quarter.
  • Across five years, Debt to Equity topped out at $0.0 in Q4 2017 and bottomed at $0.0 in Q1 2020.
  • The 4-year median for Debt to Equity is $0.0 (2019), against an average of $0.0.
  • The widest annual swing landed in 2019, when Debt to Equity fell 17.94%; it then plunged 47.41% in 2020.
  • Tracing ACIU's Debt to Equity over 4 years: stood at $0.0 in 2017, then plunged by 31.03% to $0.0 in 2018, then slipped by 17.94% to $0.0 in 2019, then tumbled by 44.46% to $0.0 in 2020.
  • Per Business Quant, the three latest ACIU Debt to Equity figures stand at $0.0 (Q3 2020), $0.0 (Q2 2020), and $0.0 (Q1 2020).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt/Equity (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn -
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 0.06
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn -
10 AC Immune 325.88 Mn 211.53 Mn - -

Historic Data

Download Data 🔒
DateValue
Sep 30, 2020 0.00
Jun 30, 2020 0.00
Mar 31, 2020 0.00
Dec 31, 2019 0.00
Sep 30, 2019 0.00
Jun 30, 2019 0.00
Mar 31, 2019 0.00
Dec 31, 2018 0.00
Dec 31, 2017 0.00
Sep 30, 2017 0.00
Jun 30, 2017 0.00